RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 12-22
  • Generic drug prices skyrocket in past year

     Generic drug prices skyrocket in past year
    After calling for a routine prescription refill, Craig Elliott got a rude shock: His bill was going up fivefold. The 44-year-old piano tuner and guitar instructor from Elgin, who has health insurance, used to pay $20 for a three-month supply of his...
  • With even some generics rising in price, explore ways to cut your drug costs

    Q: Recently, my doctor prescribed a 10-day course of doxycycline. I always ask for a generic since I need to pay full price. I was shocked when the pharmacist said it would be almost $65. I took this medication three years ago and I think it cost me...
  • Hospitals and pharmacies grapple with rising drug prices

    ST. LOUIS Fed up with the rising price of drugs, Ascension Health last month did something unusual. It publicly banned a drug company's sales reps. The reason: The company had reclassified three cancer drugs, causing prices to spike. In a memo to...
  • Allergan is in merger talks with Irish pharmaceutical firm Actavis

    Allergan is in merger talks with Irish pharmaceutical firm Actavis
    Botox maker Allergan Inc. of Irvine, which has spent six months fighting a hostile takeover attempt by a Canadian company, is in increasingly serious discussions to merge with Irish pharmaceutical firm Actavis. If Allergan agrees to be acquired by...
  • Activist investor Bill Ackman wants auction for Allergan

    Activist investor Bill Ackman wants auction for Allergan
    Activist hedge fund manager Bill Ackman on Friday urged Botox maker Allergan Inc. to put itself up for auction. The request follows Allergan’s disclosure that it is in talks to potentially merge with a firm other than the Canadian company Ackman...
  • Arrowhead Research seeks to reassure antsy investors

    Arrowhead Research seeks to reassure antsy investors
    Arrowhead Research Corp. is trying to succeed where major pharmaceutical company efforts have failed in finding a cure for one of the world's most tenacious diseases. The Pasadena biopharmaceutical company is developing so-called RNAi therapeutics. Such...
  • Local company develops training products for self-injection

    Local company develops training products for self-injection
    Twenty years ago Jeff Baker started a promotional product company in a spare bedroom in his home in Indianapolis. Today, that business, called Noble, has turned into a privately held multimillion-dollar niche product manufacturing company that takes...
  • Company denies rat poison in pills linked to India sterilization deaths

    Company denies rat poison in pills linked to India sterilization deaths
    The company at the center of a probe into why more than a dozen women died after being sterilized in India has denied that the antibiotic tablets it manufactured were contaminated with a chemical compound commonly found in rat poison. Preliminary tests...
  • Allergan, fighting off Valeant, discussing merger with another firm

    Allergan, fighting off Valeant, discussing merger with another firm
    Botox maker Allergan Inc. said it’s discussing a merger with an unnamed firm as it battles a hostile takeover by Valeant Pharmaceuticals. For six months Irvine-based Allergan has fought off an unsolicited takeover bid from Valeant...
  • Zlati Meyer: Scams spread in wake of Ebola fears

    Hey, have I got a stock tip for you! It'll make you millions of dollars in no time. There's this drug company who's discovered a cure for Ebola ... Stop right there. It's a scam. Experts are warning the public not to fall for get-rich-quick schemes...
  • Hospira profit soars despite loss of drug exclusivity

    Hospira profit soars despite loss of drug exclusivity
    Lake Forest-based drugmaker Hospira's profit skyrocketed in the third quarter compared with the same period a year earlier, mainly because of the sale of its clinical surveillance software business, Theradoc. Net income rose to $158.6 million, or 92...